Interleukin-6 (IL-6) is a multifunctional cytokine involved in essential biological processes, including cell proliferation, differentiation, and maturation, making it a key target in therapeutic development, particularly for COVID-19 treatments. Given its complex biological properties, a thorough understanding of IL-6’s aggregation behavior is critical to optimize the production and stability of anti-IL-6 therapeutic candidates. Recombinant human IL-6 (hIL-6) is typically expressed in Escherichia coli, resulting in significant formation of inclusion bodies, which presents challenges in solubility and refolding. Furthermore, IL-6 exhibits a strong propensity for aggregation, reducing the overall yield of biologically active protein after refolding. This study aimed to elucidate the underlying mechanisms of IL-6 aggregation and to identify refolding conditions that mitigate this phenomenon. Using a combination of SDS-PAGE, size-exclusion chromatography (SEC), Dynamic light scattering (DLS), and circular dichroism (CD) spectroscopy, we analyzed the dimerization and aggregation behavior of IL-6 under varying denaturation and refolding conditions. Our results suggest that IL-6 dimerizes primarily through non-covalent interactions, with its secondary structure largely preserved in the dimeric state. Comparative refolding studies under acidic and guanidine-induced denaturation conditions revealed that the rate of solvent exchange is a critical factor influencing aggregation propensity. These findings provide mechanistic insights into IL-6 aggregation during refolding and highlight strategic parameters for reducing aggregation, thereby enhancing the production yield of refolded IL-6. This work establishes a foundation for refining refolding protocols for IL-6 and potentially other aggregation-prone proteins used in therapeutic applications.
This study delves into the functional intricacies of lipoate ligase A (LplA), an enzyme showing great promise in bioconjugation due to its unique capacity for introducing azido groups into proteins without requiring a genetic tag. We aimed to enhance the understanding of LplA's functionality, particularly its substrate tolerance and the reliability of various analytical techniques. A pivotal aspect of our approach was incorporating azido groups into a range of proteins, followed by the addition of the fluorescent molecule Cy3 via click chemistry. Analysis of fluorescent intensity in the altered proteins indicated varying degrees of conjugation. Additionally, phenyl resin-based RP-HPLC facilitated effective separation of modified proteins, unmodified proteins, and remaining fluorescent tags post-separation. SASA analysis provided insights into conjugation trends, guiding the identification of proteins amenable to LplA's tag-free modification. Our findings demonstrate LplA's broad substrate tolerability for protein modification.
Tag-free protein modification by Escherichia coli lipoate ligase A (LplA) enables the installation of an azide handle onto native proteins, followed by copper-free click labeling with fluorescent probes. A practical analytical challenge in this workflow is the intact-level separation of unmodified protein, dye-conjugated protein, and residual free dye without enzymatic digestion or denaturation-based subunit analysis. Here, we describe a reversed-phase high-performance liquid chromatography with photodiode-array detection (RP-HPLC-PDA) method for intact analysis of Cy3-labeled human serum albumin (HSA) and bovine serum albumin (BSA) conjugates generated by LplA-mediated azide installation and DBCO-Cy3 labeling. Several reversed-phase column formats were compared under acidic water/acetonitrile conditions, including C18, C8, polystyrene/divinylbenzene, and polyphenyl column formats. The C8 column showed insufficient retention of intact HSA, whereas the C18 column showed severe late or incomplete elution. The polystyrene/divinylbenzene column provided only partial retention under the tested conditions. Under the common screening conditions used in this study, the BioResolve RP mAb polyphenyl column provided the most useful chromatographic profile among the tested columns. Because the tested columns differed not only in bonded-phase chemistry but also in pore size, particle size, support material, and particle morphology, the observed performance should not be attributed solely to polyphenyl surface chemistry. As an application of the method, HSA and BSA showed different apparent Cy3/protein signal ratios despite their related folds. This difference was examined using an exploratory lysine solvent-exposure analysis. The method does not by itself assign site-specific modification but provides a practical intact RP-HPLC-PDA platform for monitoring native protein-dye conjugates and selecting samples for subsequent peptide mapping or mass spectrometric characterization.